BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 743364)

  • 21. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs.
    Vasconcelos T; Sarmento B; Costa P
    Drug Discov Today; 2007 Dec; 12(23-24):1068-75. PubMed ID: 18061887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methods for estimating drug bioavailability parameters. Part 1: Concept of biological availability and methods for estimating the extent of systemic absorption.
    Firsov AA; Piotrovskii VK
    Pharmazie; 1986 May; 41(5):313-9. PubMed ID: 3737660
    [No Abstract]   [Full Text] [Related]  

  • 23. [Influence of the starting materials on bioavailability of drugs].
    Bagnaresi P; Bulgarelli D; Calvi A; Ferrarini G
    Boll Chim Farm; 1973 Feb; 112(2):83-93. PubMed ID: 4719968
    [No Abstract]   [Full Text] [Related]  

  • 24. Gastric emptying rates of drug preparations. II. Effects of size and density of enteric-coated drug preparations and food on gastric emptying rates in humans.
    Kaniwa N; Aoyagi N; Ogata H; Ejima A; Motoyama H; Yasumi H
    J Pharmacobiodyn; 1988 Aug; 11(8):571-5. PubMed ID: 3236215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An overview of the analysis and interpretation of bioavailability studies in man.
    Wagner JG
    Arzneimittelforschung; 1976; 26(1A):105-8. PubMed ID: 947190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The bioavailability of orally administered drugs with special regard to the liver as a filter for foreign matter].
    Raaflaub J
    Schweiz Med Wochenschr; 1980 Mar; 110(10):354-62. PubMed ID: 7394464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug absorption: the solution is solution.
    Lancet; 1979 Nov; 2(8150):1003-4. PubMed ID: 91725
    [No Abstract]   [Full Text] [Related]  

  • 28. [Basic pharmacokinetics--absorption].
    Slørdal L; Spigset O
    Tidsskr Nor Laegeforen; 2005 Apr; 125(7):886-7. PubMed ID: 15815736
    [No Abstract]   [Full Text] [Related]  

  • 29. Dosage and method of administration of drugs in childhood.
    Robinson GC; Williams VS
    Practitioner; 1970 Jan; 204(219):5-13. PubMed ID: 5411157
    [No Abstract]   [Full Text] [Related]  

  • 30. Methods for estimating drug bioavailability parameters. Part 2: Methods for estimating absorption rate.
    Firsov AA; Piotrovskii VK
    Pharmazie; 1986 Jun; 41(6):369-77. PubMed ID: 3763679
    [No Abstract]   [Full Text] [Related]  

  • 31. Gastrointestinal bioavailability: determination of in vivo release profiles of solid oral dosage forms by deconvolution.
    Gillespie WR; Veng-Pedersen P
    Biopharm Drug Dispos; 1985; 6(3):351-5. PubMed ID: 3840042
    [No Abstract]   [Full Text] [Related]  

  • 32. Intestinal drug absorption and bioavailability: beyond involvement of single transport function.
    Lennernäs H
    J Pharm Pharmacol; 2003 Apr; 55(4):429-33. PubMed ID: 12803763
    [No Abstract]   [Full Text] [Related]  

  • 33. Methods for estimating drug bioavailability parameters. Part 3: Peculiarities of pharmacokinetic analysis in assessment of bioavailability.
    Firsov AA; Piotrovskii VK
    Pharmazie; 1986 Jul; 41(7):457-65. PubMed ID: 3534896
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of nutrition on drug bioavailability].
    Boutin-Pannetier MS; Delhotal-Landes B; Flouvat B
    Therapie; 1986; 41(5):397-402. PubMed ID: 3544322
    [No Abstract]   [Full Text] [Related]  

  • 35. Ethanol-drug absorption interaction: potential for a significant effect on the plasma pharmacokinetics of ethanol vulnerable formulations.
    Lennernäs H
    Mol Pharm; 2009; 6(5):1429-40. PubMed ID: 19655809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of gastrointestinal drug absorption in cynomolgus monkeys.
    Takahashi M; Washio T; Suzuki N; Igeta K; Fujii Y; Hayashi M; Shirasaka Y; Yamashita S
    Mol Pharm; 2008; 5(2):340-8. PubMed ID: 18247527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Confounding factors for sex differences in pharmacokinetics and pharmacodynamics: focus on dosing regimen, dosage form, and formulation.
    Chen ML
    Clin Pharmacol Ther; 2005 Oct; 78(4):322-9. PubMed ID: 16198651
    [No Abstract]   [Full Text] [Related]  

  • 38. The mean cumulative fraction absorbed-time profiles of paracetamol as an index of gastric emptying.
    van Wyk M; Sommers DK; Meyer EC; Moncrieff J
    Methods Find Exp Clin Pharmacol; 1990 May; 12(4):291-4. PubMed ID: 2374477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioavailability of peroral dosage forms.
    Ritschel WA
    Boll Chim Farm; 1973 Mar; 112(3):137-62. PubMed ID: 4198518
    [No Abstract]   [Full Text] [Related]  

  • 40. Dissolution of drugs from solid dosage forms. I. General aspects.
    Arayne MS; Sultana N
    J Pak Med Assoc; 1979 Sep; 29(9):193-200. PubMed ID: 117153
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.